Biocon Biologics mulls raising up to Rs 4,500 crore in bonds

The company is in discussions with banks for the issuance, the people said, asking not to be named because the details are private. Funds from the bond sale will be used to refinance debt raised earlier to pay for an acquisition, with the terms yet to be finalized, they said.